Literature DB >> 30056535

Fascin protein stabilization by miR-146a implicated in the process of a chronic inflammation-related colon carcinogenesis model.

Yusuke Kanda1, Tokuichi Kawaguchi2, Mitsuhiko Osaki1,3, Kunishige Onuma1, Takahiro Ochiya4, Tomoyuki Kitagawa2, Futoshi Okada5,6.   

Abstract

OBJECTIVE: In sporadic colon tumors, multistep process of well-known genetic alterations accelerates carcinogenesis; however, this does not appear to be the case in inflammation-related ones. We previously established a model of inflammation-related colon carcinogenesis using human colonic adenoma cells, and identified fascin as a driver gene of this process. We analyzed the microRNAs involved in the stable fascin expression in colon adenocarcinoma cells.
MATERIALS AND METHODS: miRNA microarray analysis was performed using FPCK-1-1 adenoma cells and its-derived FPCKpP1-4 adenocarcinoma cells through chronic inflammation. To assess the involvement of miRNA in the inflammation-related carcinogenesis, sphere-forming ability, expression of colon cancer stemness markers, and stability of fascin protein via the proteasome using tough decoy RNA technique.
RESULTS: We found that 17 miRNAs including miR-146a were upregulated and 16 miRNAs were downregulated in FPCKpP1-4 adenocarcinoma cells. We revealed that miR-146a in the adenocarcinoma cells brought about acquisition of sphere formation, cancer stemness, and inhibition of proteasomal degradation of the fascin protein.
CONCLUSIONS: We found that stable fascin expression is brought about via the inhibition of proteasome degradation by miR-146a in the process of a chronic inflammation-related colon carcinogenesis.

Entities:  

Keywords:  Colon adenocarcinoma cells; Fascin; Inflammation-related carcinogenesis; miRNA-146a

Mesh:

Substances:

Year:  2018        PMID: 30056535     DOI: 10.1007/s00011-018-1175-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  43 in total

1.  Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Authors:  Kristiaan J Lenos; Louis Vermeulen
Journal:  Ann Transl Med       Date:  2016-12

2.  Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.

Authors:  Jingmei Lin; Noah C Welker; Zijin Zhao; Yong Li; Jianjun Zhang; Sarah A Reuss; Xinjun Zhang; Hwajeong Lee; Yunlong Liu; Mary P Bronner
Journal:  Mod Pathol       Date:  2013-09-20       Impact factor: 7.842

3.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

4.  Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts.

Authors:  Shunsuke Kitajima; Susumu Kohno; Atsushi Kondoh; Nobunari Sasaki; Yuuki Nishimoto; Fengkai Li; Mohammed Salah Abdallah Mohammed; Hayato Muranaka; Naoko Nagatani; Misa Suzuki; Yukiharu Kido; Chiaki Takahashi
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

Review 5.  Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.

Authors:  John M Carethers; Barbara H Jung
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

6.  Meta-analyses of colorectal cancer risk factors.

Authors:  Constance M Johnson; Caimiao Wei; Joe E Ensor; Derek J Smolenski; Christopher I Amos; Bernard Levin; Donald A Berry
Journal:  Cancer Causes Control       Date:  2013-04-06       Impact factor: 2.506

Review 7.  Deubiquitinating enzymes as oncotargets.

Authors:  Urszula L McClurg; Craig N Robson
Journal:  Oncotarget       Date:  2015

8.  miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.

Authors:  Yanping Liu; Wei Hong; Cancan Zhou; Zhengdong Jiang; Guanghui Wang; Guangbing Wei; Xuqi Li
Journal:  Oncol Rep       Date:  2017-04-03       Impact factor: 3.906

9.  miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.

Authors:  Min Zhang; Bing-Bin Dong; Min Lu; Mei-Juan Zheng; He Chen; Jing-Zhen Ding; A-Man Xu; Yuan-Hong Xu
Journal:  Onco Targets Ther       Date:  2016-03-03       Impact factor: 4.147

10.  MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.

Authors:  Ying-Qing Li; Jian-Hua Lu; Xue-Ming Bao; Xi-Fu Wang; Jun-Hua Wu; Wei-Qiang Hong
Journal:  J Exp Clin Cancer Res       Date:  2015-10-26
View more
  1 in total

Review 1.  Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy.

Authors:  Yu-Gui Zhang; Jiang-Tao Niu; Hong-Wei Wu; Xin-Lei Si; Shu-Juan Zhang; Dong-Hui Li; Tian-Tian Bian; Yue-Feng Li; Xing-Ke Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-05       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.